|
| |
|
|
|
|
||||
| Home Help Feedback Subscriptions Archive Search Table of Contents | ||||
Journal of Experimental Biology, Vol 204, Issue 10 1673-1686, Copyright © 2001 by Company of Biologists
JOURNAL ARTICLES |
MV St-Pierre, GA Kullak-Ublick, B Hagenbuch and PJ Meier
Division of Clinical Pharmacology and Toxicology, Department of Medicine, University Hospital, Zurich CH-8091, Switzerland. meierabt@kpt.unizh.ch
Bile acids are steroidal amphipathic molecules derived from the catabolism of cholesterol. They modulate bile flow and lipid secretion, are essential for the absorption of dietary fats and vitamins, and have been implicated in the regulation of all the key enzymes involved in cholesterol homeostasis. Bile acids recirculate through the liver, bile ducts, small intestine and portal vein to form an enterohepatic circuit. They exist as anions at physiological pH and, consequently, require a carrier for transport across the membranes of the enterohepatic tissues. Individual bile acid carriers have now been cloned from several species. Na(+)-dependent transporters that mediate uptake into hepatocytes and reabsorption from the intestine and biliary epithelium and an ATP-dependent transporter that pumps bile acids into bile comprise the classes of transporter that are specific for bile acids. In addition, at least four human and five rat genes that code for Na(+)-independent organic anion carriers with broad multi-substrate specificities that include bile acids have been discovered. Studies concerning the regulation of these carriers have permitted identification of molecular signals that dictate eventual changes in the uptake or excretion of bile acids, which in turn have profound physiological implications. This overview summarizes and compares all known bile acid transporters and highlights findings that have identified diseases linked to molecular defects in these carriers. Recent advances that have fostered a more complete appreciation for the elaborate disposition of bile acids in humans are emphasized.
This article has been cited by other articles:
|
|
 |
|
  H. Lu and C. Klaassen Gender Differences in mRNA Expression of ATP-Binding Cassette Efflux and Bile Acid Transporters in Kidney, Liver, and Intestine of 5/6 Nephrectomized Rats Drug Metab. Dispos., January 1, 2008; 36(1): 16 - 23. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Jiang, X. X. Wang, P. Scherzer, P. Wilson, J. Tallman, H. Takahashi, J. Li, M. Iwahashi, E. Sutherland, L. Arend, et al. Farnesoid X Receptor Modulates Renal Lipid Metabolism, Fibrosis, and Diabetic Nephropathy Diabetes, October 1, 2007; 56(10): 2485 - 2493. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Yamaguchi, M. Okada, S. Akitaya, H. Ohara, T. Mikkaichi, H. Ishikawa, M. Sato, M. Matsuura, T. Saga, M. Unno, et al. Transport of fluorescent chenodeoxycholic acid via the human organic anion transporters OATP1B1 and OATP1B3 J. Lipid Res., June 1, 2006; 47(6): 1196 - 1202. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Weihrauch, J. Kanchanapoo, M. Ao, R. Prasad, P. Piyachaturawat, and M. C. Rao Weanling, but not adult, rabbit colon absorbs bile acids: flux is linked to expression of putative bile acid transporters Am J Physiol Gastrointest Liver Physiol, March 1, 2006; 290(3): G439 - G450. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Lee, Y. Zhang, F. Y. Lee, S. F. Nelson, F. J. Gonzalez, and P. A. Edwards FXR regulates organic solute transporters {alpha} and {alpha} in the adrenal gland, kidney, and intestine J. Lipid Res., January 1, 2006; 47(1): 201 - 214. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. A. Alrefai, Z. Sarwar, S. Tyagi, S. Saksena, P. K. Dudeja, and R. K. Gill Cholesterol modulates human intestinal sodium-dependent bile acid transporter Am J Physiol Gastrointest Liver Physiol, May 1, 2005; 288(5): G978 - G985. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Assem, E. G. Schuetz, M. Leggas, D. Sun, K. Yasuda, G. Reid, N. Zelcer, M. Adachi, S. Strom, R. M. Evans, et al. Interactions between Hepatic Mrp4 and Sult2a as Revealed by the Constitutive Androstane Receptor and Mrp4 Knockout Mice J. Biol. Chem., May 21, 2004; 279(21): 22250 - 22257. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Kneuer, K. U. Honscha, and W. Honscha Sodium-dependent methotrexate carrier-1 is expressed in rat kidney: cloning and functional characterization Am J Physiol Renal Physiol, March 1, 2004; 286(3): F564 - F571. [Abstract] [Full Text]
|
|
|
|
|
|
R. H. Ho, B. F. Leake, R. L. Roberts, W. Lee, and R. B. Kim Ethnicity-dependent Polymorphism in Na+-taurocholate Cotransporting Polypeptide (SLC10A1) Reveals a Domain Critical for Bile Acid Substrate Recognition J. Biol. Chem., February 20, 2004; 279(8): 7213 - 7222. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Inoue, A.-M. Yu, J. Inoue, and F. J. Gonzalez Hepatocyte Nuclear Factor 4{alpha} Is a Central Regulator of Bile Acid Conjugation J. Biol. Chem., January 23, 2004; 279(4): 2480 - 2489. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Wang, Y. Han, C.-S. Kim, Y.-K. Lee, and D. D. Moore Resistance of SHP-null Mice to Bile Acid-induced Liver Damage J. Biol. Chem., November 7, 2003; 278(45): 44475 - 44481. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Hata, P. Wang, N. Eftychiou, M. Ananthanarayanan, A. Batta, G. Salen, K. S. Pang, and A. W. Wolkoff Substrate specificities of rat oatp1 and ntcp: implications for hepatic organic anion uptake Am J Physiol Gastrointest Liver Physiol, November 1, 2003; 285(5): G829 - G839. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Trauner and J. L. Boyer Bile Salt Transporters: Molecular Characterization, Function, and Regulation Physiol Rev, April 1, 2003; 83(2): 633 - 671. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Hyogo, S. Roy, B. Paigen, and D. E. Cohen Leptin Promotes Biliary Cholesterol Elimination during Weight Loss in ob/ob Mice by Regulating the Enterohepatic Circulation of Bile Salts J. Biol. Chem., September 6, 2002; 277(37): 34117 - 34124. [Abstract] [Full Text] [PDF]
|
|
